Norcliffe Capital is a venture capital firm that focuses on early-stage investments in technology companies. The firm provides capital and strategic guidance to entrepreneurs, helping them to scale their businesses and achieve long-term success.

Norcliffe Capital

With several decades of combined business experience in the life science and disruptive technology sectors, Norcliffe Capital provides more than capital to support our investments. We use our experience and expertise to select UK based growth companies in our specialist sectors and support them throughout their commercial journey.

Operating across the UK and EEA, we source companies with proven IP aiming to make a material impact in their industry, within a growing global market, where there is a clearly defined consumer need. Our investments are usually uncorrelated to the traditional investment markets and have a range of exit routes which offer the potential of generating positive investor returns. 

Norcliffe Capital works with financial advisers, wealth managers, family offices, private banks, accountants and individuals who are looking to directly invest in innovative UK companies. Our focus is on the life science and disruptive technology sectors with the potential to achieve exponential growth. Norcliffe Capital offers tax efficient ways to invest via the Enterprise Investment Scheme (EIS), SIPP, SSAS or a family investment company, as well as on a direct equity basis.

Your capital is at risk. 

Norcliffe Capital Limited is authorised and regulated by the Financial Conduct Authority (FRN 826977).

Metric
Company Name	Norcliffe Capital
Symbol
MSH ID	CAPITAL:NORCLIFFE
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Venture Capital
Country	GB
Stage
Employee Count	1
Website	norcliffe.capital
LinkedIn	norcliffe-capital-limited
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score	10.36
28-Day Growth Score	16.39
90-Day Growth Score	14.09
365-Day Growth Score	13.03

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

CAPITAL:NORCLIFFE

Norcliffe Capital

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue